© Springer-Verlag London Ltd 2008
Received: 18 January 2008
Accepted: 20 May 2008
Published: 22 August 2008
Leriche syndrome, also referred to as aortoiliac occlusive disease, is due to thrombotic occlusion of the abdominal aorta just above the site of its bifurcation.
The characteristic symptoms include inability to maintain penile erection, fatigue of both lower limbs, intermittent bilateral claudication with ischemic pain, and absent or diminished femoral pulses along with pallor or coldness of both lower extremities.
Aortoiliac occlusive disease was first described in 1814 by Robert Graham of London. Leriche syndrome was named after René Leriche, a famous French surgeon who successfully operated “his” syndrome on a 29-year-old truck driver.
Traditional surgical treatments for aortoiliac occlusive disease are aortoiliac endarterectomy (TEA) and aortobifemoral bypass (AFB). For higher-risk patients, there are alternative ways to avoid abdominal surgery such as axillofemoral bypass (extra-anatomic technique) and percutaneous transluminal angioplasty (PTA) and stenting.